Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: St. John's Wort Versus Placebo in Social Phobia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing St. John's Wort to placebo for social anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Phobic Disorders | Phase 2 | Status: COMPLETED